These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23043031)

  • 1. Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents.
    Kume T; Waseda K; Koo BK; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Yock PG; Azevedo de Oliveira FR; Abizaid A; Fitzgerald PJ; Honda Y
    J Invasive Cardiol; 2012 Oct; 24(10):489-93. PubMed ID: 23043031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
    Kume T; Waseda K; Koo BK; Yock PG; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Honda Y; Abizaid A; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):19-24. PubMed ID: 23413202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
    Jensen LO; Maeng M; Thayssen P; Villadsen A; Krusell L; Botker HE; Pedersen KE; Aaroe J; Christiansen EH; Vesterlund T; Hansen KN; Ravkilde J; Tilsted HH; Lassen JF; Thuesen L
    EuroIntervention; 2011 Jul; 7(3):323-31. PubMed ID: 21729834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
    Otake H; Honda Y; Courtney BK; Shimohama T; Ako J; Waseda K; Macours N; Rogers C; Popma JJ; Abizaid A; Ormiston JA; Spaulding C; Cohen SA; Fitzgerald PJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):146-54. PubMed ID: 21386089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
    Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial.
    Jensen LO; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Lassen JF; Thuesen L
    Eur Heart J; 2008 Nov; 29(22):2733-41. PubMed ID: 18832385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
    Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
    J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents.
    Wakabayashi K; Mintz G; Delhaye C; Choi YJ; Doh JH; Ben-Dor I; Gaglia M; Pakala R; Suddath W; Satler L; Kent K; Pichard A; Weissman N; Waksman R
    J Invasive Cardiol; 2011 Jul; 23(7):262-8. PubMed ID: 21725119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.
    Sakata K; Waseda K; Kume T; Otake H; Nakatani D; Yock PG; Fitzgerald PJ; Honda Y
    Circ Cardiovasc Interv; 2012 Dec; 5(6):763-71. PubMed ID: 23149332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound analysis of small-vessel lesions treated with novel ultra-low profile, guidewire-based self-expanding stent system.
    Koo BK; Yamasaki M; Ako J; Waseda K; Honda Y; Fitzgerald PJ; Abizaid A; Whitbourn RJ
    J Invasive Cardiol; 2008 Dec; 20(12):647-50. PubMed ID: 19057028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial.
    Windecker S; Haude M; Neumann FJ; Stangl K; Witzenbichler B; Slagboom T; Sabaté M; Goicolea J; Barragan P; Cook S; Piot C; Richardt G; Merkely B; Schneider H; Bilger J; Erne P; Waksman R; Zaugg S; Jüni P; Lefèvre T
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001441. PubMed ID: 25634905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound.
    Degertekin M; Regar E; Tanabe K; Lemos P; Lee CH; Smits P; de Feyter P; Bruining N; Sousa E; Abizaid A; Ligthart J; Serruys PW
    Am J Cardiol; 2003 May; 91(9):1046-50. PubMed ID: 12714144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
    Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
    JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.